|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
Apr 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Clarient+Enters+Partnership+to+Distribute+CombiMatrix%27s+%28CBMX%29+DNAarray+Products/6420547.html for the full story.
Globe Newswire
Apr 11
Comment
IRVINE, Calif., April 11, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into a strategic partnership with Clarient, Inc., a GE Healthcare Company, that allows Clarient the right to commercialize
Penny Stock DD
Dec 4
Comment
(RTTNews) - GE Healthcare, a unit of General Electric Co. (GE), said Friday that it is extending its tender offer for all of the outstanding capital stock of Clarient, Inc. (CLRT) to December 16.
The tender offer has been extended to allow...
FierceBiotech
Oct 25
Comment
GE on Friday announced plans to buy Clarient--a molecular diagnostics company with a strong focus on cancer markers--for $587 million. GE Healthcare is planning to build itself into a billion-dollar business marketing diagnostic solutions for...
Benzinga
Oct 22
Comment
By 10:23 am, the Dow Jones Industrial Average was down 17.79 points, or 0.16%, to 11,128.78, while the broader Standard & Poor's 500 index had gained 0.80 points, or 0.07%. The NASDAQ composite index rose 5.57 points, or 0.23%.
Some of the...
Benzinga
Oct 22
Comment
Levi & Korsinsky is investigating the Board of Directors of Clarient, Inc. (NasdaqCM: CLRT) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to GE Healthcare, a unit of...
Benzinga
Oct 22
Comment
RIT Technologies Ltd (NASDAQ: RITT) jumped 113.79% to $3.72 at 10:08 am. RITT's quarterly earnings surged 63.66% y/y.
MER Telemanagement Solutions Ltd (NASDAQ: MTSL) shares surged 86.27% to $2.35. MTSL's quarterly earnings jumped 111.35%...
Wall Street Journal
Oct 22
Comment
General Electric agreed to acquire Clarient for about $587 million as the conglomerate looks to build its disease-diagnosis capability.
MarketWatch
Oct 22
Comment
Safeguard Scientifics said Friday it will book a $145 million gain based on the sale of its partner company Clarient to a unit of General Electric . Shares of Safeguard jumped 9% to $14.93 in pre-market trades. Clairent rocketed $34% to $5 a...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
Clarient (CLRT) provides a services to assess cancer on a cellular level and to characterize the cancer. They primarily focus on solid tumors on the breast, prostate and lung.
Nov 30,2009:- Clarient Inc. has signed an exclusive license to technology aimed at making better tests for cancer. The company said it licensed a test that can identify the MUC1 protein from privately held Minerva Biotechnologies. The protein is a potential biomarker that could help identify various types of cancer. Financial terms of the deal were not disclosed. Clarient is the leading medical device maker in MUC1 protein. Clarient is investing in further developing MUC1 protein.
References
| |||||||
